Recent progress in natural products as DPP-4 inhibitors

Future Medicinal Chemistry

Volumn 7, Issue 8, 2015, Pages 1079-1089

  Gao, Yuanyuan ^a   Zhang, Yong ^b   Zhu, Jianming ^b   Li, Bo ^b   Li, Zhao ^a   Zhu, Weiliang ^b   Shi, Jiye ^c   Jia, Qi ^a   Li, Yiming ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALKALOID; ANTHOCYANIN; ANTIDIABETIC AGENT; AURANTIIN; BETA LACTOGLOBULIN; CARNOSOL; CIRSIMARITIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIPROTIN A; FLAVONOID; GLUCAGON LIKE PEPTIDE 1; GYMNEMA SYLVESTRE EXTRACT; HISPIDULIN; INCRETIN; NARINGENIN; NATURAL PRODUCT; PHENOL DERIVATIVE; PIOGLITAZONE; POLYPEPTIDE; ROSMARINIC ACID; SITAGLIPTIN; STEROID; TERPENOID; BIOLOGICAL PRODUCT; DIPEPTIDYL PEPTIDASE IV;

ANTIDIABETIC ACTIVITY; CHEMICAL STRUCTURE; DRUG MARKETING; DRUG SAFETY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; LONG TERM CARE; MOLECULAR DOCKING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; UNITED KINGDOM; CHEMISTRY; DIABETES MELLITUS, TYPE 2; ENZYMOLOGY; METABOLISM;

BIOLOGICAL PRODUCTS; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS;

EID: 84931071726     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.15.49     Document Type: Review

References (47)

1. Hung HY, Qian KD, Morris-Natschke SL, et al. Recent discovery of plant-derived anti-diabetic natural products, Nat. Prod. Rep. 29, 580-606 (2012
2. Arif T, Sharma B, Gahlaut A, et al. Anti-diabetic agents from medicinal plants: a review, Chem. Biol. Lett. 1, 1-13 (2014
3. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, World Health Organization, http: // whqlibdoc.who.int/hq/1999/who-ncd-ncs-99.2.pdf
4. Attele AS, Zhou YP, Xie JT, et al. Anti-diabetic effects of Panax ginseng berry extracts and the identification of an effective component. Diabetes 51, 1851-1858 (2002
5. Kshirsagar AD, Aggarwal AS, Harle UN, et al. DPP IV inhibitors: Ssuccesses, failures and future prospects. Diabetes Metab. Syndr. 5, 105-112 (2011
6. Wang X, Li Y, Gui XR, et al. Progress in dipeptidyl peptidase-4 and its inhibitors. Chin. Pharm. J. 48, 1789-1796 (2013
7. Gurudeeban S, Satyavani K, Ramanathan T, et al. Dipeptidyl peptidase IV inhibitors derived from a mangrove flora Rhizophora mucronata: an in silico approach. Bangladesh J. Pharmacol. 7, 203-210 (2012
8. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul. Pept. 85, 9-24 (1999
9. Holst JJ, Vilsbøll T, Deacon CF. The incretin system and its role in type 2 diabetes mellitus. Mol. Cell. Endocrinol. 297, 127-136 (2009
10. Deacon CF. Circulation and degradation of GIP and GLP-1. Horm. Metab. Res. 36, 761-765 (2004
11. Duez H, Cariou B, Staels B. DPP-4 inhibitors in the treatment of type 2 diabetes. Biochem. Pharmacol. 83, 823-832 (2012
12. Richard KR, Shelburne JS, Kirk JK. Tolerability of dipeptidyl peptidase-4 inhibitors: a review. Clin. Ther. 33, 1609-1629 (2011
13. Simpkins LM, Bolton S, Pi Z, et al. Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors. Bioorg. Med. Chem. Lett. 17, 6476-6480 (2007
14. Jia XD, Zhang J. Comparison of clinical pharmacokinetics of five marketed DPP-4 inhibitors. World Notes on Antibiotics, 35, 23-27 (2014
15. Noh YH, Lim HS, Jin SJ, et al. Effects of ketoconazole and rifampicin on the pharmacokinetics of gemigliptin, a dipeptidyl peptidase-IV inhibitor: a crossover drug-drug interaction study in healthy male Korean volunteers. Clin. Ther. 34, 1182-1194 (2012
16. Kishimoto M. Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes. Diabetes Metab. Syndr. Obes. 6, 187-195 (2013
17. Filippatos TD, Athyros VG, Elisaf MS. The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors. Expert Opin. Drug Metab. Toxicol. 10, 787-812 (2014
18. Prabhakar PK and Doble M. A Target Based Therapeutic Approach Towards Diabetes Mellitus Using Medicinal Plants. Curr. Diabetes Rev. 4, 291-308 (2008
19. Fan Jf, Johnson MH, Lila MA, et al. Berry and citrus phenolic compounds inhibit dipeptidyl peptidase IV: implications in diabetes management. Evid. Based Complement. Alternat. Med. 2013, 1-13 (2013
20. Zhang L. Identification of Isoquercitrin as a Inhibitor of DPPIV: Implications for Insulin Secretion and Hyperglycemic in Type 2 Diabetes Mice. Doctoral Dissertation, Jilin University, China, 1-99 (2013
21. Bower AM, Real Hernandez LM, Berhow MA, et al. Bioactive compounds from culinary herbs inhibit a molecular target for type-2 diabetes management, dipeptidyl peptidase-IV. J. Agric. Food Chem. 62, 6147-6158 (2014
22. Parmar HS, Jain P, Chauhan DS, et al. DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study. Diabetes Res. Clin. Pract. 97, 105-111 (2012
23. Al-masri IM, Mohammad MK, Tahaa MO. Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine. J. Enzyme Inhib. Med. Chem. 24, 1061-1066 (2009
24. Bustanji Y, Taha MO, Yousef A, et al. Berberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validation. J. Enzyme Inhib. Med. Chem. 21, 163-171 (2006
25. Guasch L, Ojeda MJ, González-Abuín N, et al. Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays. PLOS ONE 7, 1-13 (2012
26. Guasch L, Sala E, Ojeda MJ, et al. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (Part II): in silico prediction in anti-diabetic extracts. PLOS ONE 7, 1-7 (2012
27. Geng Y, Lu ZM, Huang W, et al. Bioassay-Guided Isolation of DPP-4 inhibitory fractions from extracts of submerged cultured of Inonotus obliquus. Molecules 18, 1150-1161 (2013
28. Huang NL. Inonotus obliquus. Edible Fungi of China 21, 7-8 (2002
29. Ayachi H, Merad M, Ghalem S. Study of interaction between dipeptidyl peptidase-4 and products extractsed from the stevia plant by molecular modeling. Int. J. Pharm. Sci. Rev. Res. 23, 87-90 (2013
30. Umezawa H, Aoyagi T, Ogawa K, et al. Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria. J. Antibiot. 37, 422-425 (1984
31. Pieter BJW. WO 2006068480A2 (2006
32. Huang SL, Jao CL, Ho KP, et al. Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates. Peptides 35, 114-121 (2012
33. Tulipano G, Sibilia V, Caroli MA, et al. Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors. Peptides 32, 835-838 (2011
34. Uchida M, Ohshiba Y, Mogami O. Novel Dipeptidyl Peptidase-4-Inhibiting Peptide Derived From β-Lactoglobulin. J. Pharmacol Sci. 117, 63-66 (2011
35. Tulipano G, Cocchi D, Caroli AM. Comparison of goat and sheep β-lactoglobulin to bovine β-lactoglobulin as potential source of dipeptidyl peptidase IV (DPP-4) inhibitors. Int. Dairy J. 24, 97-101 (2012
36. Li-Chan ECY, Hunag SL, Jao CL, et al. Peptides derived from atlantic salmon skin gelatin as dipeptidyl-peptidase IV iInhibitors. J. Agric. Food Chem. 60, 973-978 (2012
37. Velarde-Salcedo AJ, Barrera-Pacheco A, Lara-González S, et al. In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L) proteins. Food Chem. 136, 758-764 (2013
38. González-Abuín N, Martínez-Micaelo N, Blay M, et al. Grape seed-derived procyanidins decrease dipeptidylpeptidase 4 activity and expression. J. Agric. Food Chem. 60, 9055-9061 (2012
39. Kosaraju J, Dubala A, Chinni S, et al. A molecular connection of Pterocarpus marsupium, Eugenia jambolana and Gymnema sylvestre with dipeptidyl peptidase-4 in the treatment of diabetes. Pharm. Biol. 52, 268-271 (2014
40. Pascual I, Lopéz A, Gòmez H, et al. Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms. Enzyme Microb. Technol. 40, 414-419 (2007
41. Yang ZZ. Three Kinds of Plants in Xinjiang on Dipeptidyl Peptidase IV Inhibition Activity. Master Dissertation, Xinjiang Medical University, China, 1-45 (2012
42. Miao L. Screening the Dipeptidyl Peptidase IV Inhibitors from the Chinese Herb and its Pharmacodynamics. Master Dissertation, Jiangnan University, China, 1-44 (2008
43. Bansal P, Paul P, Mudgal J, et al. Anti-diabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L) in high fat diet/ streptozotocin-induced diabetes in mice. Exp. Toxicol. Pathol. 64, 651-658 (2012
44. Wang HJ and Chiang BH. Anti-diabetic effect of a traditional Chinese medicine formula. Food Funct. 3, 1161-1169 (2012
45. Hu JZ, Hu GW. Screeing for dipeptidyl peptidase IV inhibition research. Food Sci. Technol. 2, 42-43 (2012
46. Li WL, Wang JX, Wu XM, et al. Recent progress in research and development of dipeptidyl peptidase IV inhibitors. Chin. J. New Drugs 17, 1739-1745 (2008
47. Cragg GM, Grothaus PG, Newman DJ. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 109, 3012-3043 (2009